Tag: AbbVie
AbbVie’s $100 billion US deal & FDA reforms highlight growing focus...
Coupled with the evolving US Food and Drug Administration manufacturing reforms, the deal underscores a policy-driven shift
Ichnos Glenmark Innovation and AbbVie announce exclusive global licensing agreement for...
IGI’s lead investigational asset, ISB 2001, has been developed using IGI’s proprietary BEAT® protein platform, for oncology and autoimmune diseases
Cadila launches Adalimumab biosimilar, Cadalimab in India
In an effort to strengthen their the biosimilar product portfolio, Cadalimab™ is the fourth biosimilar launched in the last 2 months by Cadila Pharmaceuticals..................
Alvotech & Cipla Gulf join hands to commercialize key biosimilar in...
Under the partnership, Alvotech will be responsible for development and supply of AVT02, an adalimumab biosimilar, in select emerging markets., while Cipla Gulf will be responsible for registration and commercialization....................